Immunosuppressive myeloid cells are recognized as a key barrier for cancer immunotherapy. Using an integrated technology for single-cell RNA-sequencing and intracellular protein measurements, A recent paper published in Cell provides evidence that TREM2 was identified as a marker for tumor-associated macrophages (TAMs) and monocytes. 1
No takes yet. Share an insight, caveat, or question.
Nakamura et al. (2020) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: